Denis Burger

Denis R.
Burger was the founder of Epitope, Inc., founded in 1981, where the title held was Chairman from 1981 to 1990.
Dr. Burger was the founder of Trinity Biotech Plc, founded in 1992, where the title held was Lead Independent Non-Executive Director from 1992 to 2020.
Dr. Burger currently holds the position of Executive Chairman at Biocide, Inc. since 2009.
Dr. Burger is Chairman at AMES Technology, Inc. Dr. Burger is President at Yamhill Valley Vineyards, Inc. since 1983.
Dr. Burger is Partner at Sovereign Ventures LLC.
Dr. Burger is Managing Member at Paradigm Ventures LLC since 1990.
Former positions include Chairman & Chief Executive Officer at Sarepta Therapeutics, Inc. from 1996 to 2007.
Chairman & Chief Executive Officer at AVI Biopharma, Inc. Vice Chairman & Chief Science Officer at CytoDyn, Inc. from 2016 to 2018.
Executive Chairman at BioCurex, Inc. Director at Paulson Capital (Delaware) Corp.
from 2007 to 2009 and from 2013 to 2014.
Lead Independent Director at Aptose Biosciences, Inc. from 2007 to 2026.
Professor-Microbiology & Immunology at Oregon Health & Science University from 1969 to 1985.
Education includes undergraduate degree from the University of California, Berkeley in 1965, and graduate and doctorate degrees from the University of Arizona in 1969.